Takeda Pharmaceuticals America, INC.
Pharmaceuticals
Based in DC
AI Overview
With $530K in lobbying spend across 14 quarterly filings, Takeda Pharmaceuticals America, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $90K |
| 2022 | $160K |
| 2023 | $180K |
| 2024 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Takeda Pharmaceuticals America, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Proposals related to health equity, including but not limited to: clinical trial diversity, issues of patient assistance programs, and social determinants of health; and
Proposals related to drug pri
Proposals related to health equity, including but not limited to: clinical trial diversity, issues of patient assistance programs, and social determinants of health; and Proposals related to drug pric
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.